Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Scleroderma Treatment market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Scleroderma Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Scleroderma Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
F Hoffmann-La Roche
Corbus Pharmaceuticals
F. Hoffmann-La Roche
Merck
Bayer AG
CELGENE
Novartis
AstraZeneca
Sanofi
GlaxoSmithKline
Boehringer Ingelheim
Biogen
Amgen
By Type:
Anti-inflammatory Drugs
Stem cell transplant
Immunosuppressants
PDE5 Inhibitors
Calcium Channel Blockers
By End-User:
Hospitals
Clinics
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Scleroderma Treatment Market
-
1.3 Market Segment by Type
1.3.1 Japan Scleroderma Treatment Market Size and Growth Rate of Anti-inflammatory Drugs from 2014 to 2026
1.3.2 Japan Scleroderma Treatment Market Size and Growth Rate of Stem cell transplant from 2014 to 2026
1.3.3 Japan Scleroderma Treatment Market Size and Growth Rate of Immunosuppressants from 2014 to 2026
1.3.4 Japan Scleroderma Treatment Market Size and Growth Rate of PDE5 Inhibitors from 2014 to 2026
1.3.5 Japan Scleroderma Treatment Market Size and Growth Rate of Calcium Channel Blockers from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Scleroderma Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Japan Scleroderma Treatment Market Size and Growth Rate of Clinics from 2014 to 2026
1.4.3 Japan Scleroderma Treatment Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Scleroderma Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Scleroderma Treatment by Major Types
3.4.1 Market Size and Growth Rate of Anti-inflammatory Drugs
3.4.2 Market Size and Growth Rate of Stem cell transplant
3.4.3 Market Size and Growth Rate of Immunosuppressants
3.4.4 Market Size and Growth Rate of PDE5 Inhibitors
3.4.5 Market Size and Growth Rate of Calcium Channel Blockers
4 Segmentation of Scleroderma Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Scleroderma Treatment by Major End-Users
4.4.1 Market Size and Growth Rate of Scleroderma Treatment in Hospitals
4.4.2 Market Size and Growth Rate of Scleroderma Treatment in Clinics
4.4.3 Market Size and Growth Rate of Scleroderma Treatment in Others
5 Market Analysis by Regions
-
5.1 Japan Scleroderma Treatment Production Analysis by Regions
-
5.2 Japan Scleroderma Treatment Consumption Analysis by Regions
6 Hokkaido Scleroderma Treatment Landscape Analysis
-
6.1 Hokkaido Scleroderma Treatment Landscape Analysis by Major Types
-
6.2 Hokkaido Scleroderma Treatment Landscape Analysis by Major End-Users
7 Tohoku Scleroderma Treatment Landscape Analysis
-
7.1 Tohoku Scleroderma Treatment Landscape Analysis by Major Types
-
7.2 Tohoku Scleroderma Treatment Landscape Analysis by Major End-Users
8 Kanto Scleroderma Treatment Landscape Analysis
-
8.1 Kanto Scleroderma Treatment Landscape Analysis by Major Types
-
8.2 Kanto Scleroderma Treatment Landscape Analysis by Major End-Users
9 Chubu Scleroderma Treatment Landscape Analysis
-
9.1 Chubu Scleroderma Treatment Landscape Analysis by Major Types
-
9.2 Chubu Scleroderma Treatment Landscape Analysis by Major End-Users
10 Kinki Scleroderma Treatment Landscape Analysis
-
10.1 Kinki Scleroderma Treatment Landscape Analysis by Major Types
-
10.2 Kinki Scleroderma Treatment Landscape Analysis by Major End-Users
11 Chugoku Scleroderma Treatment Landscape Analysis
-
11.1 Chugoku Scleroderma Treatment Landscape Analysis by Major Types
-
11.2 Chugoku Scleroderma Treatment Landscape Analysis by Major End-Users
12 Shikoku Scleroderma Treatment Landscape Analysis
-
12.1 Shikoku Scleroderma Treatment Landscape Analysis by Major Types
-
12.2 Shikoku Scleroderma Treatment Landscape Analysis by Major End-Users
13 Kyushu Scleroderma Treatment Landscape Analysis
-
13.1 Kyushu Scleroderma Treatment Landscape Analysis by Major Types
-
13.2 Kyushu Scleroderma Treatment Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 F Hoffmann-La Roche
14.1.1 F Hoffmann-La Roche Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Corbus Pharmaceuticals
14.2.1 Corbus Pharmaceuticals Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 F. Hoffmann-La Roche
14.3.1 F. Hoffmann-La Roche Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Merck
14.4.1 Merck Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Bayer AG
14.5.1 Bayer AG Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 CELGENE
14.6.1 CELGENE Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Novartis
14.7.1 Novartis Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 AstraZeneca
14.8.1 AstraZeneca Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Sanofi
14.9.1 Sanofi Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 GlaxoSmithKline
14.10.1 GlaxoSmithKline Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Boehringer Ingelheim
14.11.1 Boehringer Ingelheim Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Biogen
14.12.1 Biogen Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Amgen
14.13.1 Amgen Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
The List of Tables and Figures (Totals 145 Figures and 151 Tables)
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Anti-inflammatory Drugs from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Stem cell transplant from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Immunosuppressants from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of PDE5 Inhibitors from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Calcium Channel Blockers from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Scleroderma Treatment Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Scleroderma Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Scleroderma Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Scleroderma Treatment by Different Types from 2014 to 2026
-
Table Consumption Share of Scleroderma Treatment by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Anti-inflammatory Drugs
Figure Market Size and Growth Rate of Stem cell transplant
Figure Market Size and Growth Rate of Immunosuppressants
Figure Market Size and Growth Rate of PDE5 Inhibitors
Figure Market Size and Growth Rate of Calcium Channel Blockers
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Scleroderma Treatment by Different End-Users from 2014 to 2026
-
Table Consumption Share of Scleroderma Treatment by Different End-Users from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Scleroderma Treatment Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Scleroderma Treatment Production by Regions
-
Table Japan Scleroderma Treatment Production Share by Regions
-
Figure Japan Scleroderma Treatment Production Share by Regions in 2014
-
Figure Japan Scleroderma Treatment Production Share by Regions in 2018
-
Figure Japan Scleroderma Treatment Production Share by Regions in 2026
-
Table Japan Scleroderma Treatment Consumption by Regions
-
Table Japan Scleroderma Treatment Consumption Share by Regions
-
Figure Japan Scleroderma Treatment Consumption Share by Regions in 2014
-
Figure Japan Scleroderma Treatment Consumption Share by Regions in 2018
-
Figure Japan Scleroderma Treatment Consumption Share by Regions in 2026
-
Table Hokkaido Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Hokkaido Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Hokkaido Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Hokkaido Scleroderma Treatment Consumption Share by Types in 2026
-
Table Hokkaido Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Hokkaido Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Hokkaido Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Tohoku Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Tohoku Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Tohoku Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Tohoku Scleroderma Treatment Consumption Share by Types in 2026
-
Table Tohoku Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Tohoku Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Tohoku Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Tohoku Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Kanto Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Kanto Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Kanto Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Kanto Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Kanto Scleroderma Treatment Consumption Share by Types in 2026
-
Table Kanto Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Kanto Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Kanto Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Kanto Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Chubu Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Chubu Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Chubu Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Chubu Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Chubu Scleroderma Treatment Consumption Share by Types in 2026
-
Table Chubu Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Chubu Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Chubu Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Chubu Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Kinki Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Kinki Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Kinki Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Kinki Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Kinki Scleroderma Treatment Consumption Share by Types in 2026
-
Table Kinki Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Kinki Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Kinki Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Kinki Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Chugoku Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Chugoku Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Chugoku Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Chugoku Scleroderma Treatment Consumption Share by Types in 2026
-
Table Chugoku Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Chugoku Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Chugoku Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Chugoku Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Shikoku Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Shikoku Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Shikoku Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Shikoku Scleroderma Treatment Consumption Share by Types in 2026
-
Table Shikoku Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Shikoku Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Shikoku Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Shikoku Scleroderma Treatment Consumption Share by End-Users in 2026
-
Table Kyushu Scleroderma Treatment Consumption by Types from 2014 to 2026
-
Table Kyushu Scleroderma Treatment Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Scleroderma Treatment Consumption Share by Types in 2014
-
Figure Kyushu Scleroderma Treatment Consumption Share by Types in 2018
-
Figure Kyushu Scleroderma Treatment Consumption Share by Types in 2026
-
Table Kyushu Scleroderma Treatment Consumption by End-Users from 2014 to 2026
-
Table Kyushu Scleroderma Treatment Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Scleroderma Treatment Consumption Share by End-Users in 2014
-
Figure Kyushu Scleroderma Treatment Consumption Share by End-Users in 2018
-
Figure Kyushu Scleroderma Treatment Consumption Share by End-Users in 2026
Table Company Profile and Development Status of F Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
Table Product and Service Introduction of F Hoffmann-La Roche
Table Company Profile and Development Status of Corbus Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Corbus Pharmaceuticals
Figure Sales and Growth Rate Analysis of Corbus Pharmaceuticals
Figure Revenue and Market Share Analysis of Corbus Pharmaceuticals
Table Product and Service Introduction of Corbus Pharmaceuticals
Table Company Profile and Development Status of F. Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche
Table Product and Service Introduction of F. Hoffmann-La Roche
Table Company Profile and Development Status of Merck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
Figure Sales and Growth Rate Analysis of Merck
Figure Revenue and Market Share Analysis of Merck
Table Product and Service Introduction of Merck
Table Company Profile and Development Status of Bayer AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
Figure Sales and Growth Rate Analysis of Bayer AG
Figure Revenue and Market Share Analysis of Bayer AG
Table Product and Service Introduction of Bayer AG
Table Company Profile and Development Status of CELGENE
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CELGENE
Figure Sales and Growth Rate Analysis of CELGENE
Figure Revenue and Market Share Analysis of CELGENE
Table Product and Service Introduction of CELGENE
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Sanofi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
Figure Sales and Growth Rate Analysis of Sanofi
Figure Revenue and Market Share Analysis of Sanofi
Table Product and Service Introduction of Sanofi
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Boehringer Ingelheim
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
Table Product and Service Introduction of Boehringer Ingelheim
Table Company Profile and Development Status of Biogen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
Figure Sales and Growth Rate Analysis of Biogen
Figure Revenue and Market Share Analysis of Biogen
Table Product and Service Introduction of Biogen
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
-
